METTL3 and malignant colon neoplasm: Moreover, of the m6A modulators, METTL3 is a key component of the m6A methylation complex and is reportedly involved in hepatocellular carcinoma (Chen et al., 2018), breast cancer (Wang et al., 2020), and colon cancer (Peng et al., 2019).